Recent findings have demonstrated that glutamine-addicted breast cancer cells exhibit a capacity to adapt to chronic glutamine starvation or GLS inhibition through AMPK-mediated upregulation of the serine synthesis pathway. Here, GLS is linked to breast cancer.